Montelukast Sodium
- All
- News
-
Jubilant Life Sciences Surges 9% on New Drug Approval
As on December 31, 2014, Jubilant Life Sciences had a total of 781 filings for formulations, of which, 333 have been approved in various regions globally.
-
Glenmark Generics recalls anti-asthma drug from US market
Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration.
-
Dr Reddy's launches asthma drug in US market
Montelukast Sodium tablets, generic versions of Merck & Co's Singulair tablets, are used for treating asthma.
-
Aurobindo, Glenmark get USFDA nod for generic asthma drug
The annual sales of montelukast sodium tablets stood at $4.5 billion for the twelve months ending March 2012.
-
Jubilant Life Sciences Surges 9% on New Drug Approval
As on December 31, 2014, Jubilant Life Sciences had a total of 781 filings for formulations, of which, 333 have been approved in various regions globally.
-
Glenmark Generics recalls anti-asthma drug from US market
Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration.
-
Dr Reddy's launches asthma drug in US market
Montelukast Sodium tablets, generic versions of Merck & Co's Singulair tablets, are used for treating asthma.
-
Aurobindo, Glenmark get USFDA nod for generic asthma drug
The annual sales of montelukast sodium tablets stood at $4.5 billion for the twelve months ending March 2012.
